Emphysema
📧 Sign up to get email alerts when something new happens for Emphysema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD [Phase 3]
Phase 3 trial evaluating the safety and efficacy of (R,R)-formoterol in COPD, including chronic bronchitis and emphysema, has completed. Spo…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD [Phase 3]
Phase 3 study assessing long-term safety of (R,R)-formoterol in COPD subjects has completed; detailed results are not provided in the snippe…
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Use of Endobronchial Valves in Non-Upper Lobe Heterogeneous Emphysema [Phase 3]
A Phase 3 clinical trial evaluating endobronchial valves for non-upper lobe heterogeneous emphysema has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-24Clinical Trial Update: Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study [Phase 2]
Aeris Therapeutics' Phase 2 Biologic Lung Volume Reduction study in homogeneous emphysema has completed, with results reported.
-
CLINICAL_TRIALS trial_result · 2011-10-21Clinical Trial Update: AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema [Phase 2, Phase 3]
Clinical trial update indicating completion of Phase 2 and Phase 3 studies evaluating the AeriSeal System for lung volume reduction in advan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-10-21Clinical Trial Update: A Dose Ranging Study of the Aeris Polymeric Lung Volume Reduction (PLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema [Phase 1]
Phase 1 dose-ranging trial of the Aeris Polymeric Lung Volume Reduction (PLVR) System in patients with advanced emphysema has completed.
-
FDA approval · 2011-10-07FDA Approved: COMBIVENT RESPIMAT — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved Combivent Respimat (ipratropium bromide and albuterol) in an original application for relief of bronchospasm associated with ch…
-
CLINICAL_TRIALS research · 2011-09-09Clinical Trial Update: Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype [Phase 4]
A Phase 4 clinical trial is evaluating how exercise training affects systemic inflammation and muscle repair across COPD phenotypes, with cu…
-
CLINICAL_TRIALS trial_result · 2011-08-05Clinical Trial Update: Simvastatin in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 clinical trial evaluating simvastatin for chronic obstructive pulmonary disease (including emphysema) is reported, but the status …
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema
Completed clinical trial focused on phenotypic characterization of patients with combined pulmonary fibrosis and emphysema.
-
CLINICAL_TRIALS trial_result · 2011-06-16Clinical Trial Update: Pilot Study of the Spiration IBV™ System [Phase 2]
A Phase 2 pilot trial of the Spiration IBV System for emphysema has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Effectiveness of Different Exercise Training Programs to the Profile of COPD Patients [Phase 4]
A Phase 4 clinical trial comparing different exercise training programs in patients with chronic obstructive pulmonary disease (COPD), inclu…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Efficacy Study of the Effect of Budesonide on Emphysema [Phase 4]
A Phase 4 efficacy study evaluating budesonide for emphysema associated with COPD has completed, sponsored by AstraZeneca.
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: EASE Trial: Exhale Airway Stents for Emphysema [Phase 3]
This document notes a Phase 3 clinical trial (EASE) evaluating Exhale Airway Stents for emphysema; the current status is unknown.
-
CLINICAL_TRIALS research · 2010-12-07Clinical Trial Update: Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema
ClinicalTrials.gov update regarding management of patients with Alpha-1 antitrypsin deficiency–associated emphysema; no results or conclusio…
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: Distribution of Regional Lung Function by Vibration Response Imaging
This clinical trial update presents results on regional lung function distribution measured by Vibration Response Imaging in patients with e…
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: Inhaled Steroid Reduces Systemic Inflammation in COPD [Phase 4]
A Phase 4 trial found that an inhaled corticosteroid reduces systemic inflammation in chronic obstructive pulmonary disease.
-
FDA approval · 2010-07-13FDA Approved: THEOPHYLLINE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's Theophylline from an Original Application; Theophylline is a bronchodilator used to treat symptoms of obstructive ai…
-
CLINICAL_TRIALS withdrawal · 2010-01-18Clinical Trial Update: Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema [Phase 3]
Phase 3 study of the Biologic Lung Volume Reduction System for advanced upper lobe predominant emphysema has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Real-Time Support for Exercise Persistence in COPD [Phase 1, Phase 2]
This update summarizes a Phase 1/2 trial evaluating real-time support to help patients with chronic obstructive pulmonary disease persist wi…
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients [Phase 4]
Phase 4 trial evaluating whether adding tiotropium to formoterol improves exercise tolerance in patients with chronic obstructive pulmonary …
-
CLINICAL_TRIALS trial_result · 2009-08-18Clinical Trial Update: Endobronchial Valve for Emphysema Palliation Trial (VENT) [Phase 3]
A Phase 3 trial (VENT) evaluating an endobronchial valve for palliation of emphysema in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-18Clinical Trial Update: Endobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-Study [Phase 3]
The Phase 3 Endobronchial Valve for Emphysema Palliation (VENT) cost-effectiveness sub-study has been terminated; no efficacy results are re…
-
CLINICAL_TRIALS other · 2009-06-16Clinical Trial Update: Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure
Clinical trial update indicates the Vibration Response Imaging study for patients planned for pulmonary operation is suspended.
-
CLINICAL_TRIALS trial_result · 2009-04-02Clinical Trial Update: Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 study evaluated the efficacy and safety of an arformoterol and tiotropium combination versus each therapy alone in chronic obstruc…